Specialty Diagnostics — Cost of revenues

Business Segments · Cost of revenues

Thermo Fisher Scientific Specialty Diagnostics — Cost of revenues increased by 2.1% to $682.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $668.00M to $682.00M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ3 2025

How to read this metric

A rising ratio relative to revenue suggests margin compression, while a falling ratio indicates improved manufacturing efficiency.

Detailed definition

The direct costs attributable to the production and delivery of diagnostic products and services within the Specialty Di...

Peer comparison

Standard metric for assessing gross margin health across the life sciences industry.

Metric ID: tmo_segment_specialty_diagnostics_cost_of_revenues

Historical Data

6 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q3 '25
Value$646.00M$646.00M$646.00M$646.00M$668.00M$682.00M
QoQ Change+0.0%+0.0%+0.0%+3.4%+2.1%
YoY Change+3.4%+2.1%
Range$646.00M$682.00M
CAGR+4.4%
Avg YoY Growth+2.8%
Median YoY Growth+2.8%
Current Streak5+ quarters growth

Frequently Asked Questions

What is Thermo Fisher Scientific's specialty diagnostics — cost of revenues?
Thermo Fisher Scientific (TMO) reported specialty diagnostics — cost of revenues of $682.00M in Q3 2025.
How has Thermo Fisher Scientific's specialty diagnostics — cost of revenues changed year-over-year?
Thermo Fisher Scientific's specialty diagnostics — cost of revenues increased by 2.1% year-over-year, from $668.00M to $682.00M.
What does specialty diagnostics — cost of revenues mean?
The direct costs required to produce and sell the goods and services in the Specialty Diagnostics segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.